Australia's most trusted
source of pharma news
Posted 19 June 2025 PM
Co-founder of Rare Cancers Australia (RCA), Richard Vines, is stepping down from his position as inaugural Chair at the end of the month, marking exactly a year-and-a-half since he passed the baton of CEO to Christine Cockburn.
The announcement also coincides with an update on Kate Vines health and treatment in her latest tilt against medullary thyroid cancer. Earlier this week, Vines revealed in a LinkedIn video that the theranostic treatment his wife received did not work and that their focus has been on managing her pain and letting her body recover.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.